Palvella Therapeutics Q4 EPS $(1.08) Misses $(0.91) Estimate
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. PVLA | 0.00 |
Palvella Therapeutics (NASDAQ:
PVLA) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.91) by 18.29 percent. This is a 79.89 percent increase over losses of $(5.37) per share from the same period last year.
